Live Virtual Briefing will be conducted in Chinese with simultaneous interpretation in English.
网络直播研讨会将以普通话进行，并提供英语即时翻译
Loading feed
Speakers
Confirm cancellation
Something went wrong.
An error occurred trying to play the stream. Please reload the page and try again.
Close
Managing Director and Head of Everbright Healthcare Fund. Prior to Everbright, Mr. Fu worked as head of healthcare PE at Hillhouse, head of China healthcare at TPG Growth Capital, head of healthcare at FountainVest Partners and CITIC Pacific.
Mr. Fu has over 16 years’ experiences in investment, transactions range from early stage, growth to buyout. He has led and participated in investments in CP Guojian, CITIC Pharma, Lifetech, Fussen, Wuxi, Daopei, Amcare, Junshi and etc.
Prior to investment career, Mr. Fu had 8 years’ experience in operation with Sanjiu Pharmaceutical. He was the National Head of Sales and Marketing, responsible for both in-house products and exclusive agency business with multinational pharmaceutical companies.
Mr. Fu received MBA from University of British Columbia and Bachelor Degree of Economics and International Finance from East China Normal University. He is a CFA Charter holder as well.
刘晓岚先生2006年加入中信证券，拥有超过10年的医疗健康行业投行工作经验。曾作为项目负责人或现场负责人参与了以岭药业、中信国健、滇虹药业、益丰药房、沈阳三生、大理药业、赛诺医疗（科创板）等IPO项目、南京医药再融资、益丰药房可转债、哈药股份重大资产重组、益丰药房重大收购项目，并在灵康药业及甘李药业IPO等项目担任核心成员或技术支持工作。此外还参与了部分非医药类项目，包括中化国际分离交易可转债、中华企业再融资、南京新百重大资产重组、印度公司并购境内塑料制品企业等项目，拥有丰富的资本运作及项目经验。
刘晓岚先生毕业于加拿大McMaster大学，获工商管理硕士学位。
Mr. Josh SHIN specializes in Mergers & Acquisitions, equity financing and advices on regulatory issues, with a strong track record in various industry sectors such as pharma, life science, healthcare, education and general industry. He currently acts as coordinator of Fangda’s healthcare practices, and has been named as leading individual in life sciences by Chambers Asia Pacific and Legal 500 for years.
Speaker bio coming soon
首席财务官朱杰伦全面负责公司的财务策略和管理、投资规划、企业融资以及资本市场和投资者关系。他是金融领域的专家，经验丰富，拥有超过11年的投行工作经历。在加入天境生物之前，从2015年12月到2018年7月，朱杰伦在香港担任富瑞集团董事总经理以及亚洲医疗健康行业的主管，主要负责投资银行部门及资本市场业务。在富瑞集团就职期间，他主导了大中华及其它地区的一系列具有市场影响力的生物科技和医疗健康项目，包括IPO首发上市、兼并收购以及其他战略性交易。在加入富瑞集团之前，朱杰伦就职于德意志银行（香港），是负责覆盖医疗行业的资深投资银行家之一。在德意志银行之前，朱杰伦曾在瑞士银行集团香港任职。在进入投资银行之前，朱杰伦曾在波士顿地区从事专注于美国大型制药以及生物科技企业的战略咨询工作。 朱杰伦2007年6月以卓越学生的荣誉毕业于哈佛大学商学院，获得工商管理硕士学位。之前他在美国卫斯理大学学习数学经济学，并以优异的成绩获得本科荣誉学位。他同时也是特许金融分析师。
Toto Ku is the Head of Greater China at Datasite (formerly Merrill Corporation), responsible for the company’s rapid growth in the mainland. He leads the expansion of Datasite’s footprint in the market, now trusted by thousands of corporates and PEs in China to securely source, manage and execute their deals and transactions faster.
Toto has more than 10 years’ experience in the finance industry, holding senior management roles in portfolio companies of KKR, Bain Capital and other global organizations, with a focus on financial technologies.
He specializes in helping global companies establish their footprint in China, successfully developing multiple opportunities for business growth over the past decade. Toto also has set up several real estate brokerage firms in Hong Kong serving hedge funds and PEs.
Yiqing Wang is China Editor, and APAC Assistant Editor for Mergermarket, a global news intelligence service for advisors, private equity firms and corporates. She leads a team of dedicated journalists across Greater China to cover PE/VC fundraising, M&A deals, PE buyouts and China cross-border M&A intelligence.
Yiqing has been an investigative M&A reporter and researcher since 2009, writing industry news ranging from healthcare, new energy and financial service, etc. She achieved her master’s degree of multilingual multicultural studies from New York University.